Back to Markets
GNGenelux Corp

Genelux Corp

GNLXNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$3.05

-0.020000 (-0.65%)

As of 05/29/26 EDT · USD

Compare
Low: $2.29Current: $3.05High: $8.54

Key Statistics

Open

$3.08

Day High

$3.09

Day Low

$3.02

Prev. Close

$3.07

VolumeShares traded today.

110.25K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$136.76M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.58

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$8.54

52W LowLowest price over the past 52 weeks.

$2.29

50D MAAverage closing price over the last 50 trading days.

$2.72

200D MAAverage closing price over the last 200 trading days.

$3.77

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+4.5%

1M

+22.0%

6M

-42.3%

YTD

-33.0%

1Y

+26.0%

About

Genelux Corporation is a publicly traded late clinical-stage company developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus (VACV), a stable DNA virus with a large engineering capacity.

genelux.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade GNLX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.